Hepatitis C in France: A National Survey in the Departments of Internal Medicine and Infectious Diseases
Infection with Hepatitis C virus is a significant public health problem that has important clinical and financial consequences. Understanding of the epidemiology of HCV is needed to help defined future therapeutic and preventìve strategies. So far, the importance and characteristics of the epidemics...
Gespeichert in:
| Veröffentlicht in: | European journal of epidemiology 1998-09, Vol.14 (6), p.545-548 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 548 |
|---|---|
| container_issue | 6 |
| container_start_page | 545 |
| container_title | European journal of epidemiology |
| container_volume | 14 |
| creator | Raguin, Gilles Rosenthal, Eric Cacoub, Patrice Veyssier, Pierre Piette, Jean-Charles Micoud, Max GERMIVIC (Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases) |
| description | Infection with Hepatitis C virus is a significant public health problem that has important clinical and financial consequences. Understanding of the epidemiology of HCV is needed to help defined future therapeutic and preventìve strategies. So far, the importance and characteristics of the epidemics have been best appreciated in specialist units dealing with liver disease. The purpose of our study was to survey the number and characteristics of hepatitis C antibody positive patients in Departments of Internal Medicine and Infectious Diseases. we conducted a multicentre national prospective analysis of all positive HCV-antibody patients, either inpatient or outpatient, reported over a period of one month across France. Two thousand and two cases were identified. Epidemiological clinical and therapeutic characteristics are described. Risk factors were identified in 86%. For 10% of the patients, hepatitis C seropositivity was discovered during the period of survey. At the time of first diagnosis, 47% of patients presented with no clinical or biological abnormality. Coinfection with HIV was frequent (59%). Only 20.3% of the patients had received or were receiving a treatment with interferon. Within the limits of the methodology used, this study shows that Hepatitis C infection is a substantial clinical problem in French Departments of Internal Medicine and Infectious Diseases. Our findings may help the public health authorities in better appreciating the impact of hepatitis C and making policy decisions. |
| doi_str_mv | 10.1023/A:1007430812081 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_17273976</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>3581737</jstor_id><sourcerecordid>3581737</sourcerecordid><originalsourceid>FETCH-LOGICAL-j262t-5d0c883a9fdcfe85724988c742052d3bac303d6c48920ac222983fb88c0d0e8b3</originalsourceid><addsrcrecordid>eNpd0EFLwzAUAOAgCs7p2YuHgOKt-pK0TbLb2JwOph7Uc8nSV5bStbPJhP17MzY8eHg8eO97j5cQcs3ggQEXj-MRA5CpAMV4jBMyYJkUieQqPSUDEFokXGs4Jxfe1wCgQGcDsnrBjQkuOE8n1LV01pvW4oiO6Vssd61p6Me2_8HdvhlWSKfR92GNbfC0q-i8Ddjv1SuWzroWqWnLWK3QxvGtp1Pn0Xj0l-SsMo3Hq2Mekq_Z0-fkJVm8P88n40VS85yHJCvBKiWMrkpbocokT7VSVqYcMl6KpbECRJnbVGkOxnLOtRLVMhIoAdVSDMn9Ye-m77636EOxdt5i05gW4z0Fk1wKLfMIb__ButvunxINMJlnmcp1VHdHZbw1TbX_HueLTe_Wpt8VPGUsnhLZzYHVPnT9X1tkikkhxS-5gXuU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017655869</pqid></control><display><type>article</type><title>Hepatitis C in France: A National Survey in the Departments of Internal Medicine and Infectious Diseases</title><source>SpringerNature Journals</source><source>JSTOR Archive Collection A-Z Listing</source><creator>Raguin, Gilles ; Rosenthal, Eric ; Cacoub, Patrice ; Veyssier, Pierre ; Piette, Jean-Charles ; Micoud, Max ; GERMIVIC (Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases)</creator><creatorcontrib>Raguin, Gilles ; Rosenthal, Eric ; Cacoub, Patrice ; Veyssier, Pierre ; Piette, Jean-Charles ; Micoud, Max ; GERMIVIC (Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases)</creatorcontrib><description>Infection with Hepatitis C virus is a significant public health problem that has important clinical and financial consequences. Understanding of the epidemiology of HCV is needed to help defined future therapeutic and preventìve strategies. So far, the importance and characteristics of the epidemics have been best appreciated in specialist units dealing with liver disease. The purpose of our study was to survey the number and characteristics of hepatitis C antibody positive patients in Departments of Internal Medicine and Infectious Diseases. we conducted a multicentre national prospective analysis of all positive HCV-antibody patients, either inpatient or outpatient, reported over a period of one month across France. Two thousand and two cases were identified. Epidemiological clinical and therapeutic characteristics are described. Risk factors were identified in 86%. For 10% of the patients, hepatitis C seropositivity was discovered during the period of survey. At the time of first diagnosis, 47% of patients presented with no clinical or biological abnormality. Coinfection with HIV was frequent (59%). Only 20.3% of the patients had received or were receiving a treatment with interferon. Within the limits of the methodology used, this study shows that Hepatitis C infection is a substantial clinical problem in French Departments of Internal Medicine and Infectious Diseases. Our findings may help the public health authorities in better appreciating the impact of hepatitis C and making policy decisions.</description><identifier>ISSN: 0393-2990</identifier><identifier>EISSN: 1573-7284</identifier><identifier>DOI: 10.1023/A:1007430812081</identifier><identifier>CODEN: EJEPE8</identifier><language>eng</language><publisher>Dordrecht: Kluwer Academic Publishers</publisher><subject>Biological and medical sciences ; Coinfection ; Epidemiology ; Hepacivirus ; Hepatitis ; Hepatitis C ; Hepatitis C virus ; HIV ; Human viral diseases ; Infections ; Infectious diseases ; Internal medicine ; Liver ; Medical sciences ; Predisposing factors ; Public health ; Risk factors ; Viral diseases ; Viral hepatitis</subject><ispartof>European journal of epidemiology, 1998-09, Vol.14 (6), p.545-548</ispartof><rights>Copyright 1998 Kluwer Academic Publishers</rights><rights>1998 INIST-CNRS</rights><rights>Kluwer Academic Publishers 1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/3581737$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/3581737$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2411489$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Raguin, Gilles</creatorcontrib><creatorcontrib>Rosenthal, Eric</creatorcontrib><creatorcontrib>Cacoub, Patrice</creatorcontrib><creatorcontrib>Veyssier, Pierre</creatorcontrib><creatorcontrib>Piette, Jean-Charles</creatorcontrib><creatorcontrib>Micoud, Max</creatorcontrib><creatorcontrib>GERMIVIC (Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases)</creatorcontrib><title>Hepatitis C in France: A National Survey in the Departments of Internal Medicine and Infectious Diseases</title><title>European journal of epidemiology</title><description>Infection with Hepatitis C virus is a significant public health problem that has important clinical and financial consequences. Understanding of the epidemiology of HCV is needed to help defined future therapeutic and preventìve strategies. So far, the importance and characteristics of the epidemics have been best appreciated in specialist units dealing with liver disease. The purpose of our study was to survey the number and characteristics of hepatitis C antibody positive patients in Departments of Internal Medicine and Infectious Diseases. we conducted a multicentre national prospective analysis of all positive HCV-antibody patients, either inpatient or outpatient, reported over a period of one month across France. Two thousand and two cases were identified. Epidemiological clinical and therapeutic characteristics are described. Risk factors were identified in 86%. For 10% of the patients, hepatitis C seropositivity was discovered during the period of survey. At the time of first diagnosis, 47% of patients presented with no clinical or biological abnormality. Coinfection with HIV was frequent (59%). Only 20.3% of the patients had received or were receiving a treatment with interferon. Within the limits of the methodology used, this study shows that Hepatitis C infection is a substantial clinical problem in French Departments of Internal Medicine and Infectious Diseases. Our findings may help the public health authorities in better appreciating the impact of hepatitis C and making policy decisions.</description><subject>Biological and medical sciences</subject><subject>Coinfection</subject><subject>Epidemiology</subject><subject>Hepacivirus</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>Hepatitis C virus</subject><subject>HIV</subject><subject>Human viral diseases</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Internal medicine</subject><subject>Liver</subject><subject>Medical sciences</subject><subject>Predisposing factors</subject><subject>Public health</subject><subject>Risk factors</subject><subject>Viral diseases</subject><subject>Viral hepatitis</subject><issn>0393-2990</issn><issn>1573-7284</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpd0EFLwzAUAOAgCs7p2YuHgOKt-pK0TbLb2JwOph7Uc8nSV5bStbPJhP17MzY8eHg8eO97j5cQcs3ggQEXj-MRA5CpAMV4jBMyYJkUieQqPSUDEFokXGs4Jxfe1wCgQGcDsnrBjQkuOE8n1LV01pvW4oiO6Vssd61p6Me2_8HdvhlWSKfR92GNbfC0q-i8Ddjv1SuWzroWqWnLWK3QxvGtp1Pn0Xj0l-SsMo3Hq2Mekq_Z0-fkJVm8P88n40VS85yHJCvBKiWMrkpbocokT7VSVqYcMl6KpbECRJnbVGkOxnLOtRLVMhIoAdVSDMn9Ye-m77636EOxdt5i05gW4z0Fk1wKLfMIb__ButvunxINMJlnmcp1VHdHZbw1TbX_HueLTe_Wpt8VPGUsnhLZzYHVPnT9X1tkikkhxS-5gXuU</recordid><startdate>19980901</startdate><enddate>19980901</enddate><creator>Raguin, Gilles</creator><creator>Rosenthal, Eric</creator><creator>Cacoub, Patrice</creator><creator>Veyssier, Pierre</creator><creator>Piette, Jean-Charles</creator><creator>Micoud, Max</creator><creator>GERMIVIC (Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases)</creator><general>Kluwer Academic Publishers</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>3V.</scope><scope>7QL</scope><scope>7T2</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>19980901</creationdate><title>Hepatitis C in France: A National Survey in the Departments of Internal Medicine and Infectious Diseases</title><author>Raguin, Gilles ; Rosenthal, Eric ; Cacoub, Patrice ; Veyssier, Pierre ; Piette, Jean-Charles ; Micoud, Max ; GERMIVIC (Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases)</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j262t-5d0c883a9fdcfe85724988c742052d3bac303d6c48920ac222983fb88c0d0e8b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Biological and medical sciences</topic><topic>Coinfection</topic><topic>Epidemiology</topic><topic>Hepacivirus</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>Hepatitis C virus</topic><topic>HIV</topic><topic>Human viral diseases</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Internal medicine</topic><topic>Liver</topic><topic>Medical sciences</topic><topic>Predisposing factors</topic><topic>Public health</topic><topic>Risk factors</topic><topic>Viral diseases</topic><topic>Viral hepatitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raguin, Gilles</creatorcontrib><creatorcontrib>Rosenthal, Eric</creatorcontrib><creatorcontrib>Cacoub, Patrice</creatorcontrib><creatorcontrib>Veyssier, Pierre</creatorcontrib><creatorcontrib>Piette, Jean-Charles</creatorcontrib><creatorcontrib>Micoud, Max</creatorcontrib><creatorcontrib>GERMIVIC (Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases)</creatorcontrib><collection>Pascal-Francis</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>European journal of epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raguin, Gilles</au><au>Rosenthal, Eric</au><au>Cacoub, Patrice</au><au>Veyssier, Pierre</au><au>Piette, Jean-Charles</au><au>Micoud, Max</au><au>GERMIVIC (Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases)</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hepatitis C in France: A National Survey in the Departments of Internal Medicine and Infectious Diseases</atitle><jtitle>European journal of epidemiology</jtitle><date>1998-09-01</date><risdate>1998</risdate><volume>14</volume><issue>6</issue><spage>545</spage><epage>548</epage><pages>545-548</pages><issn>0393-2990</issn><eissn>1573-7284</eissn><coden>EJEPE8</coden><abstract>Infection with Hepatitis C virus is a significant public health problem that has important clinical and financial consequences. Understanding of the epidemiology of HCV is needed to help defined future therapeutic and preventìve strategies. So far, the importance and characteristics of the epidemics have been best appreciated in specialist units dealing with liver disease. The purpose of our study was to survey the number and characteristics of hepatitis C antibody positive patients in Departments of Internal Medicine and Infectious Diseases. we conducted a multicentre national prospective analysis of all positive HCV-antibody patients, either inpatient or outpatient, reported over a period of one month across France. Two thousand and two cases were identified. Epidemiological clinical and therapeutic characteristics are described. Risk factors were identified in 86%. For 10% of the patients, hepatitis C seropositivity was discovered during the period of survey. At the time of first diagnosis, 47% of patients presented with no clinical or biological abnormality. Coinfection with HIV was frequent (59%). Only 20.3% of the patients had received or were receiving a treatment with interferon. Within the limits of the methodology used, this study shows that Hepatitis C infection is a substantial clinical problem in French Departments of Internal Medicine and Infectious Diseases. Our findings may help the public health authorities in better appreciating the impact of hepatitis C and making policy decisions.</abstract><cop>Dordrecht</cop><pub>Kluwer Academic Publishers</pub><doi>10.1023/A:1007430812081</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0393-2990 |
| ispartof | European journal of epidemiology, 1998-09, Vol.14 (6), p.545-548 |
| issn | 0393-2990 1573-7284 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_17273976 |
| source | SpringerNature Journals; JSTOR Archive Collection A-Z Listing |
| subjects | Biological and medical sciences Coinfection Epidemiology Hepacivirus Hepatitis Hepatitis C Hepatitis C virus HIV Human viral diseases Infections Infectious diseases Internal medicine Liver Medical sciences Predisposing factors Public health Risk factors Viral diseases Viral hepatitis |
| title | Hepatitis C in France: A National Survey in the Departments of Internal Medicine and Infectious Diseases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T07%3A30%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hepatitis%20C%20in%20France:%20A%20National%20Survey%20in%20the%20Departments%20of%20Internal%20Medicine%20and%20Infectious%20Diseases&rft.jtitle=European%20journal%20of%20epidemiology&rft.au=Raguin,%20Gilles&rft.date=1998-09-01&rft.volume=14&rft.issue=6&rft.spage=545&rft.epage=548&rft.pages=545-548&rft.issn=0393-2990&rft.eissn=1573-7284&rft.coden=EJEPE8&rft_id=info:doi/10.1023/A:1007430812081&rft_dat=%3Cjstor_proqu%3E3581737%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1017655869&rft_id=info:pmid/&rft_jstor_id=3581737&rfr_iscdi=true |